MB
Mahendrakumar Bhagwatbhai Gajjar
About Mahendrakumar Bhagwatbhai Gajjar
Data last updated:
Mahendrakumar Bhagwatbhai Gajjar was a Director at Scai Superspeciality Hospitals Private Limited (2021–2023), Director at Green Cross Genetics Lab Private Limited (2017–2019) and Director at Shraddhadeep Pathology And Research Centre Private Limited (from 2008). The companies operate in Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Aug 2021 | 2021 | ₹4.00 Cr (FY 2024) | Active | |
| Director | 17 Jun 2017 | 2014 | ₹13.25 Cr (FY 2022) | Active | |
| Director | 11 Jun 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahendrakumar Bhagwatbhai Gajjar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahendrakumar Bhagwatbhai Gajjar
Mahendrakumar Bhagwatbhai Gajjar was first appointed on 11 Jun 2008 as Director at Shraddhadeep Pathology And Research Centre Private Limited. The most recent appointment on record is 18 Aug 2021 at Scai Superspeciality Hospitals Private Limited.
Mahendrakumar Bhagwatbhai Gajjar held 3 earlier board appointments: Scai Superspeciality Hospitals Private Limited (Director, 18 Aug 2021 to 25 Feb 2023); Green Cross Genetics Lab Private Limited (Director, 17 Jun 2017 to 12 Jun 2019); Shraddhadeep Pathology And Research Centre Private Limited (Director, from 11 Jun 2008).